lactose has been researched along with glycopyrrolate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guthrie, AJ; Kutscha, J; Preston, T; Sutton, DG | 1 |
| Clark, AR; Colthorpe, P; Haynes, A; Khindri, SK; Machineni, S; Perry, SA; Rao, N; Ung, K; Weers, JG | 1 |
1 trial(s) available for lactose and glycopyrrolate
| Article | Year |
|---|---|
Equine piroplasmosis treatment protocols: specific effect on orocaecal transit time as measured by the lactose 13C-ureide breath test.
Topics: Animals; Atropine; Babesiosis; Carbon Isotopes; Drug Interactions; Gastrointestinal Motility; Glycopyrrolate; Heart Rate; Horse Diseases; Horses; Imidocarb; Lactose; Respiration; Urea | 2012 |
1 other study(ies) available for lactose and glycopyrrolate
| Article | Year |
|---|---|
In Vitro-In Vivo Correlations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler®.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aerosols; Biological Availability; Bronchodilator Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Delivery Systems; Dry Powder Inhalers; Equipment Design; Glycopyrrolate; Humans; Indans; Lactose; Models, Anatomic; Models, Biological; Muscarinic Antagonists; Particle Size; Pharynx; Powders; Quinolones; Therapeutic Equivalency; Tissue Distribution | 2015 |